Buprenorphine Extended-Release Injection and Ranibizumab
Determining the interaction of Buprenorphine Extended-Release Injection and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Ranibizumab Intraocular
- Buprenorphine Extended-Release Injection-Ranibizumab ophthalmic
- Buprenorphine Extended-Release Injection-Ranitidine
- Buprenorphine Extended-Release Injection-Ranitidine Capsule
- Buprenorphine Extended-Release Injection-Ranitidine Hydrochloride
- Buprenorphine Extended-Release Injection-Ranitidine Injection
- Ranibizumab-Buprenorphine implant
- Ranibizumab-Buprenorphine Injection
- Ranibizumab-Buprenorphine injection - Buprenex
- Ranibizumab-Buprenorphine injection - Sublocade
- Ranibizumab-Buprenorphine Intradermal
- Ranibizumab-Buprenorphine oral/buccal